Sign in: Staff/Students
The University of Liverpool, along with the Liverpool School of Tropical Medicine (LSTM) and the Japanese pharmaceutical company, Eisai, have received funding from the Global Health Innovative Technology (GHIT) Fund to continue the development of a new antimalarial compound, E209.
E209 was discovered through joint research by the University and LSTM and is a novel tetraoxane-based second generation antimalarial candidate compound.
Research so far has shown that it is rapidly acting and shows efficacy against all types of malaria parasites, which means that it could be effective in patients for whom artemisinin-based malaria treatments are ineffective due to resistance.
The award means that the team will now prepare the compound for candidate selection and marks an important step on the journey to becoming a new drug in the fight against malaria.
Professor O’Neill, Head of the Medicinal Chemistry Team at the University that developed E209, said “ This new award, which follows on from initial Medicines for Malaria Venture (MMV) funding , will enable us to continue to develop E209 as an alternative to the natural product derived artemisinins .
“With growing evidence of resistance to all current antimalarial therapies, it is vitally important that we are able to move ahead with this compound which, at this stage, appears to be effective against all plasmodium parasites.”
The GHIT Fund facilitates and funds global partnerships for the discovery and development of new health technologies, including drugs, vaccines and diagnostics, for infectious and neglected tropical diseases prevalent in developing countries.
You must be logged in to post a comment.
All recent news
Becoming an Expert: Using data science to identify health inequalities for people with dementia
REMINDER: Library resources and support
Postcard: Citizens’ jury debate ethical use of electronic health data in Uganda
Institute of Irish Studies’ first Artist in Residence, Fion Gunn brings exhibition to VG&M
"We hosted what we believe may have been the first healthcare-related citizens' jury in Uganda, which aimed to garner attitudes towards the use of electronic medical data in the research context."
@LivUniISMIB @IDIMakerere #Postcard #PublicEngagement https://news.liverpool.ac.uk/2022/08/12/postcard-citizens-jury-debate-ethical-use-of-electronic-health-data-in-uganda/
Check out the new blog from @Jasmine_Grace_ from @LivUniPsyc, @livuniIPH
Why not join Jasmine and the team at the @World_Museum on Sat 20th August at 11am to bust taboos, dispel myths and learn about #menstrualcycles and #periods
Read her blog here: https://tinyurl.com/LivUniBlogJW
There's still a few days left to see our own Professor Tom Solomon @RunningMadProf performing his 'Covid for Kids' show at #EdinburghFringe!
All the details + booking info for the final few tickets here ➡️ https://www.pleasance.co.uk/event/covid-kids#overview